Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹131.67Admitted-Finance | ₹131.67 | L1 | Admitted-Finance |
| 2 | L2₹1,723.68Admitted-Finance | ₹1,723.68 | L2 | Admitted-Finance |
| 3 | L3₹15,518.39Admitted-Finance 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 | HYDERABAD | HYDERABAD | TELANGANA | 500016 | ₹15,518.39 | L3 | Admitted-Finance |
| 4 | L4₹19,770.37Admitted-Finance S 2 GROUND FLOOR OKHLA INDUSTRIAL AREA PHASE II NEW DELHI DELHI 110020 UDYAM DL 09 0021388 04AARCM6226E1ZH B 07AARCM6226E1ZB R 19AARCM6226E1Z6 B 27AARCM6226E1Z9 B 09AARCM6226E1Z7 B | SOUTH EAST DELHI | DELHI | 110020 | ₹19,770.37 | L4 | Admitted-Finance |
| 5 | L5₹1.7 LAdmitted-Finance 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002 | ₹1.7 L | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Shiva Medical Agencies L2 | Dr Reddys Laboratories Limited L3 | Takeda Biopharmaceuticals India Private Limited L5 | Medikon India Private Limited L4 | CANBERRA PHARMA L1 |
|---|---|---|---|---|---|---|---|---|
| 1.00 | Inj Brentuximab Vedotin 50 mg | 1 | Vial | - | - | 1,58,624.22 ₹1,66,555.43 Lowest | - | - |
| 2.00 | Inj Evolocumab 140 mg | 2 | Vial | - | 15,518.39 ₹15,518.39 Lowest | - | - | - |
| 3.00 | Inj Semaglutide 0.5 mg | 1 | PFS | 1,641.6 ₹1,723.68 Lowest | - | - | - | - |
| 4.00 | Fluticasone Furoate, Umeclidinium and Vilanterol 100 mcg/62.5 mcg/25mcg Multi Dose Dry Powder Inhaler of 30 doses | 2 | Pack | - | - | - | 2,328.92 ₹2,445.37 Lowest | - |
| 5.00 | Drain bag for peritoneal dialysis 3000 ml | 1 | No | - | - | - | - | 125.4 ₹131.67 Lowest |
| 6.00 | Inj Tremelimumab 300 mg | 2 | Vial | - | - | - | - | - |
| 7.00 | Inj Tirzepatide 10 mg | 1 | PFS | - | - | - | 16,500 ₹17,325 Lowest | - |
Tender Value
Refer Docs
Closing Date
22 Jul 2026, 10:00 amClosed
COMMANDING OFFICER
MH TRIVANDRUM
PROCUREMENT OF MEDICINE
2026_ARMY_778779_1
200294/DGLP/ECHS/IFA/75/2026
Open Tender
Drugs and Pharmaceutical Products
Buy
30 days
MH TRIVANDRUM
AS PER TENDER DOCUMENT
3 documents required · 3 mandatory
₹0
Exempted
24 Jul 2026
15 Jul 2026
22 Jul 2026
15 Jul 2026
22 Jul 2026
15 Jul 2026
15 Jul 2026 - 22 Jul 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Inj Brentuximab Vedotin 50 mg | 1 | Vial | - | - |
| 2 | Inj Evolocumab 140 mg | 2 | Vial | - | - |
| 3 | Inj Semaglutide 0.5 mg | 1 | PFS | - | - |
| 4 | Fluticasone Furoate, Umeclidinium and Vilanterol 100 mcg/62.5 mcg/25mcg Multi Dose Dry Powder Inhaler of 30 doses | 2 | Pack | - | - |
| 5 | Drain bag for peritoneal dialysis 3000 ml | 1 | No | - | - |
| 6 | Inj Tremelimumab 300 mg | 2 | Vial | - | - |
| 7 | Inj Tirzepatide 10 mg | 1 | PFS | - | - |
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.19 MB
BOQ_872256.xls
BOQ • 0.40 MB
RFPIFA75.pdf
Tender Documents • 1.23 MB
ManufacturerQuoted.xls
Additional Documents • 0.15 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].